| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HRTHM.2009.11.027 |
| P698 | PubMed publication ID | 20185109 |
| P50 | author | Bruce Wilkoff | Q46383130 |
| P2093 | author name string | Michael O Sweeney | |
| Mark S Wathen | |||
| Lou Sherfesee | |||
| Paul J DeGroot | |||
| P433 | issue | 3 | |
| P921 | main subject | defibrillator | Q1450682 |
| P304 | page(s) | 353-360 | |
| P577 | publication date | 2009-12-02 | |
| P1433 | published in | Heart Rhythm | Q2058605 |
| P1476 | title | Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients | |
| P478 | volume | 7 |
| Q51624768 | "Virtual research" may point the way towards future device programming trials. |
| Q36594611 | 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing |
| Q58819090 | 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing |
| Q44228404 | A randomized-controlled pilot study comparing ICD implantation with and without intraoperative defibrillation testing in patients with heart failure and severe left ventricular dysfunction: a substudy of the RAFT trial |
| Q38221790 | Adverse events following implantable cardioverter defibrillator implantation: a systematic review |
| Q57492869 | Amiodarone and the thyroid physiology, pathophysiology, diagnosis and management |
| Q50682438 | An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study. |
| Q61716598 | An Entirely Subcutaneous Implantable Cardioverter–Defibrillator |
| Q39365813 | Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review |
| Q34977631 | Appropriate and Inappropriate Electrical Therapies Delivered by an Implantable Cardioverter-Defibrillator: Effect on Intracardiac Electrogram |
| Q38442126 | Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. |
| Q38995761 | Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator |
| Q44456856 | Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial |
| Q38236610 | Catheter ablation of ventricular tachycardia in patients with post-infarction cardiomyopathy |
| Q33162261 | Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication |
| Q89228060 | Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation? |
| Q44220449 | Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis |
| Q40608250 | Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms |
| Q57626635 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
| Q57626770 | EHRA/HRS/APHRS expert consensus on ventricular arrhythmias |
| Q40392631 | Effect of ICD Therapies on Mortality in the OMNI Trial |
| Q44063975 | Efficacy of tuned waveforms based on different membrane time constants on defibrillation thresholds: primary results from the POWER trial |
| Q33166181 | Evaluation of defibrillation safety and shock reduction in implantable cardioverter-defibrillator patients with increased time to detection: A randomized SANKS study. |
| Q38051118 | How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection? |
| Q51625587 | ICD Therapy--Can We Make a Life-Saving Device Less Lethal? |
| Q38211070 | ICD programming to reduce shocks and improve outcomes |
| Q90047120 | ICD shocks in LVAD patients are not associated with increased subsequent mortality risk |
| Q42754427 | ICD shocks: not just the "straw that broke the camel's back". |
| Q55474867 | INvestigation on Routine Follow-up in CONgestive HearT FAilure Patients with Remotely Monitored Implanted Cardioverter Defibrillators SysTems (InContact). |
| Q89126764 | Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy |
| Q34723139 | Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention |
| Q33644319 | Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator |
| Q42363086 | Limitations and Challenges in Mapping Ventricular Tachycardia: New Technologies and Future Directions |
| Q28468706 | Long-Term Follow-Up of Catheter Ablation of Ventricular Arrhythmias: Experiences from a Tertiary Referral Center in Taiwan |
| Q38477990 | Management of ventricular arrhythmias in structural heart disease |
| Q37859647 | Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes. |
| Q34728838 | Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease |
| Q27348940 | Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof-of-Concept from Experimental Studies to Clinical VF. |
| Q33163249 | Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study. |
| Q41628438 | Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry |
| Q90372170 | Myocardial Minimal Damage After Rapid Ventricular Pacing - the prospective randomized multicentre MyDate-Trial |
| Q47097637 | Newly developed atrial fibrillation progresses to a more severe INTERMACS score in a patient with advanced heart failure due to dilated cardiomyopathy |
| Q93061681 | Optogenetic Termination of Cardiac Arrhythmia: Mechanistic Enlightenment and Therapeutic Application? |
| Q99632372 | Outcome of catheter ablation in the very elderly-insights from a large matched analysis |
| Q37155195 | Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. |
| Q64103455 | Prognostic Importance of Defibrillator-Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure |
| Q38364204 | Programming implantable cardioverter/defibrillators and outcomes |
| Q33159661 | Progress in cardiac electrophysiology and arrhythmias |
| Q35107904 | Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). |
| Q35915639 | Psychosocial and cardiac outcomes of yoga for ICD patients: a randomized clinical control trial. |
| Q33163845 | Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. |
| Q33873348 | Recent advances in the management of ventricular tachyarrhythmias. |
| Q38411076 | Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study |
| Q55274291 | Risk factors and prognostic role of an electrical storm in patients after myocardial infarction with an implanted ICD for secondary prevention. |
| Q41008815 | Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study |
| Q90319195 | Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices |
| Q43892315 | Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? |
| Q36742973 | Spironolactone Therapy is Associated with Reduced Ventricular Tachycardia Rate in Patients with Cardiomyopathy |
| Q50686443 | Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model. |
| Q38940666 | Substrate-Based Ablation Versus Ablation Guided by Activation and Entrainment Mapping for Ventricular Tachycardia: A Systematic Review and Meta-Analysis. |
| Q40311907 | Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice |
| Q90224837 | The Effect of Shock Burden on Heart Failure and Mortality |
| Q45968620 | The Relationship of Antitachycardia Pacing versus Shock in an Implantable Cardioverter-Defibrillator Population and the Risk of Mortality: Just an Association? |
| Q38951636 | The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. |
| Q43638454 | The association between ICD interventions and mortality is independent of their modality: clinical implications |
| Q44205988 | The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators. |
| Q37963831 | The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response? |
| Q48138307 | The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators |
| Q58814898 | Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention |
| Q47681875 | Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate |
| Q38819031 | Ventricular fibrillation: triggers, mechanisms and therapies |
| Q84348228 | [Is intraoperative ICD-testing still necessary?] |
Search more.